GLP-1 Weight-Loss Medication in China: Semaglutide, Tirzepatide and Supervised Treatment for International Patients

GLP-1 receptor agonists — the medicines behind brand names such as Ozempic, Wegovy and Mounjaro — have changed the conversation around weight and metabolic health worldwide. Across the Gulf, where rates of obesity and type 2 diabetes are among the highest globally, demand is high but supply is often limited and prices steep, with long private-clinic waiting lists.

This guide explains what GLP-1 medicines are, who they are for, and how a medically supervised treatment plan — paired with a proper metabolic check — works in China.

Please note: This article is general education, not medical advice or a prescription. GLP-1 medicines are prescription-only and must be started and monitored by a qualified doctor, who will confirm whether they are appropriate and safe for you.

What are GLP-1 medicines?

GLP-1 (glucagon-like peptide-1) receptor agonists mimic a natural gut hormone that helps regulate blood sugar and appetite. In practice they:

• Slow stomach emptying so you feel full for longer
• Reduce appetite and food cravings by acting on the brain's hunger signals
• Improve blood sugar control, which is why several were first approved for type 2 diabetes

The two families most people ask about:

• Semaglutide (the molecule in Ozempic and Wegovy) — a once-weekly injection
• Tirzepatide (the molecule in Mounjaro) — a dual GLP-1/GIP agonist, also once-weekly, often associated with greater average weight loss

Who are they for?

GLP-1 treatment is generally considered for people who:

• Have a higher body-mass index (BMI), particularly with weight-related conditions such as type 2 diabetes, high blood pressure, high cholesterol or sleep apnea
• Have struggled to reach a healthy weight through diet and lifestyle alone
• Are willing to combine medication with sustained changes to diet, activity and sleep

They are not a quick fix or a cosmetic shortcut. A doctor will assess your full picture first, because these medicines are not suitable for everyone (for example in pregnancy, or with certain thyroid, pancreatic or gastrointestinal conditions) and can have side effects — most commonly nausea, which usually eases as the dose is increased gradually.

Why patients look to China

China has invested heavily in metabolic medicine, and both semaglutide and tirzepatide are approved and widely used in major hospitals. For international patients this means:

• Access without long waiting lists — assessment, prescription and the first supervised doses can typically be arranged within your visit
• A meaningful price advantage — partly because these medicines are now produced and supplied at scale domestically, in-hospital prices for tirzepatide have fallen substantially in the past year
• Specialist supervision — treatment is started by an endocrinology or metabolic specialist after proper testing, not bought blind online

A common, sensible itinerary pairs a comprehensive metabolic check (so you and your doctor know your real starting point) with a specialist consultation to decide whether GLP-1 treatment is appropriate.

How supervised treatment works

1. Metabolic assessment — blood sugar (HbA1c), insulin resistance, lipids, liver and kidney function, thyroid and blood pressure, so underlying causes are ruled out and the plan is safe.
2. Specialist consultation — an endocrinologist reviews your history and goals and decides whether a GLP-1 medicine is suitable, and which one.
3. Initiation and titration — if appropriate, treatment is started at a low dose and increased gradually under medical guidance to minimise side effects.
4. A plan to continue — diet, activity and follow-up monitoring, so results are sustainable rather than rebounding once treatment changes.

Important: how the medication is provided

This is where international patients most often have questions, so to be clear:

• GLP-1 medicines are prescription-only and are prescribed and dispensed by the licensed hospital in China, after in-person assessment.
• SinoCareLink is a healthcare coordination and facilitation service. We arrange the appointment, hospital coordination and English-speaking support — we do not prescribe medication and we do not ship injectables across borders.
• Whether you may carry a personal supply home depends on your own country's import and customs rules for prescription medicines. Always check these in advance; your treating doctor can advise on continuing care.
• GLP-1 injections require cold-chain storage, which is another reason cross-border shipping is not offered.

A whole-person view

Medication works best as one part of a bigger picture. Improving metabolic health — blood sugar, blood pressure, cholesterol and waist size — matters more than the number on the scale alone. Many patients also combine medical care with Traditional Chinese Medicine support for weight and metabolism, and with the everyday foundations — food quality, movement, sleep and stress — that make any treatment more effective.

For Gulf and overseas patients

If you are travelling to China for treatment, a typical plan combines a metabolic health check with a specialist consultation, with English-speaking coordination throughout. We can help you understand what is involved, what to prepare, and how to arrange follow-up before you decide.

Take the next step

👉 Contact SinoCareLink to ask about a supervised metabolic check and specialist consultation in China.

Keep reading

• Diabetes, prediabetes & metabolic health check in China
• Weight management & metabolic health: how Chinese medicine can support your journey

Frequently asked questions

What is the difference between semaglutide and tirzepatide?
Both are once-weekly injections that reduce appetite and improve blood sugar. Semaglutide acts on the GLP-1 pathway, while tirzepatide acts on two pathways (GLP-1 and GIP) and is often associated with greater average weight loss. A specialist will advise which, if either, is right for you.

Are GLP-1 medicines available in China?
Yes. Both semaglutide and tirzepatide are approved and used in major Chinese hospitals, and are prescribed after in-person assessment by a specialist.

Why is treatment in China often cheaper?
These medicines are now produced and supplied at scale domestically, and in-hospital prices — especially for tirzepatide — have fallen substantially over the past year compared with many private clinics abroad. Final cost depends on the medicine, dose and your treatment plan.

Can SinoCareLink ship the medication to my country?
No. GLP-1 injections are prescription-only, require cold-chain storage, and are dispensed by the licensed hospital in China. We coordinate appointments and support but do not prescribe or ship medication. Whether you may carry a personal supply home depends on your own country's import rules.

Do I still need a health check if I just want the medication?
Yes. A metabolic assessment lets the doctor confirm the treatment is appropriate and safe, rule out underlying causes, and monitor you properly. GLP-1 medicines are started and supervised by a doctor, not bought blind.

Is medication enough on its own?
No. The best results come from combining medication with changes to diet, activity, sleep and follow-up monitoring, so progress is sustainable.